2022
DOI: 10.1186/s43166-022-00126-0
|View full text |Cite
|
Sign up to set email alerts
|

Hematological markers and ultrasound 7-joint inflammation score as add-on tools in the assessment of inflammation in rheumatoid arthritis patients

Abstract: Background Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and joint destruction that eventually induces severe disability. Inflammation is the key determinant and primary underlying mechanism leading to disability and increased mortality in patients with RA. This study aimed to correlate the hematological markers and ultrasound 7-joint inflammation score to disease activity in rheumatoid arthritis patients. Results … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 57 publications
0
0
0
Order By: Relevance
“…The current research suggests that ineffective treatment of RA may lead to joint damage and increase the disease activity.The levels of the hematological parameters (hemoglobin, WBC, and platelet) showed a non-significant difference among the four RA disease activity groups according to both DAS-28 ESR and DAS-28 CRP. This results aligns with Gaballah et al (2022). Moreover, van Riel (2014) found a nonsignificant differences between hemoglobin and disease activity and Ming Yang et al (2018) found a non-significant difference between WBC and DAS-28 ESR, while platelets showed significant differences with DAS-28 ESR.…”
Section: Discussionsupporting
confidence: 79%
“…The current research suggests that ineffective treatment of RA may lead to joint damage and increase the disease activity.The levels of the hematological parameters (hemoglobin, WBC, and platelet) showed a non-significant difference among the four RA disease activity groups according to both DAS-28 ESR and DAS-28 CRP. This results aligns with Gaballah et al (2022). Moreover, van Riel (2014) found a nonsignificant differences between hemoglobin and disease activity and Ming Yang et al (2018) found a non-significant difference between WBC and DAS-28 ESR, while platelets showed significant differences with DAS-28 ESR.…”
Section: Discussionsupporting
confidence: 79%